(62) reviewed and analyzed the clinical and imaging data of 109 patients with advanced NSCLC treated with PD-1/PD-L1 immunosuppressant monotherapy, of whom 19 showed hyperprogression. The gene discussed is CD274; the disease is non-small cell lung carcinoma.